Oragenics, Inc. (OGEN)
0.9129
-0.01
(-0.77%)
USD |
NYAM |
Jan 15, 12:56
Oragenics SG&A Expense (TTM): 6.832M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |
| Theriva Biologics, Inc. | 16.21M |
| NanoViricides, Inc. | 3.611M |
| Actinium Pharmaceuticals, Inc. | 15.79M |